Italy undertakes bold measures on transparency by adopting the Pricing and Reimbursement Decree

On Friday, 24 July 2020, Italy officially published the long-anticipated Pricing and Reimbursement Decree in the Gazzetta Ufficiale della Repubblica Italiana setting in motion Italy’s place as the first country to implement the WHO transparency resolution (WHA72.8). In statement before… Continue Reading

WTO TRIPS Council (July 2020): The European Union’s position on the interface of IP and health technologies in the COVID-19 response

On 30 July 2020, the World Trade Organization (WTO) convened a formal meeting of the TRIPS Council. The TRIPS Council held discussions on two COVID-19 related topics: agenda item 3 on IP Measures in the Context of COVID-19 and agenda… Continue Reading

KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards

KEI has a number of outstanding requests under the United States Freedom of Information Act (FOIA) for contracts related to biomedical innovations to control or treat the COVID-19 pandemic. On Thursday, June 25, and Friday, June 26, we received a… Continue Reading

WTO TRIPS Council (informal): South Africa’s interventions on COVID-19, TRIPS flexibilities, and domestic manufacturing capacity

On Friday, 19 June 2020, the World Trade Organization (WTO) convened an informal virtual Open-ended Meeting of the TRIPS Council. . The following statements were delivered by South Africa at the virtual open-ended informal meeting of the TRIPS Council. In… Continue Reading

EU Trade Commissioner Phil Hogan issues statement on European Union compulsory licensing in context of COVID-19, makes important statement about TRIPS Article 31bis

On 14 May 2020, Bernd Lange, Chair of the European Parliament’s Committee on International Trade (INTA) wrote a letter to Phil Hogan (Commissioner for Trade, European Commission) on the “commercial aspects of intellectual property rights for medical products in the… Continue Reading

AstraZeneca, Pfizer, IFPMA on the WHO COVID-19 Pool at May 28, 2020 IFPMA Press Briefing

At a May 28,2020 press briefing organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), pharma CEOs and the IFPMA DG commented on the WHO proposal for a global pool for rights in technologies for the diagnosis, prevention… Continue Reading

Patents related to PX-UV, an R2-D2 look-alike robot that may disinfect public spaces from SARS-CoV-2

Texas-based company Xenex Disinfection Services, a manufacturer of robots that reportedly removes the SARS-CoV-2 virus from public spaces, has been making news lately. One of their robots, which uses ultraviolet lights to kill viruses and bacteria in surfaces and look… Continue Reading